<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29016856</article-id>
<article-id pub-id-type="pmc">5886211</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddx289</article-id>
<article-id pub-id-type="publisher-id">ddx289</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Copping</surname>
<given-names>Nycole A</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
<author-comment content-type="other">
<p>
<sup>†</sup>Equally contributing first authors.</p>
</author-comment>
<xref ref-type="author-notes" rid="ddx289-FM1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Christian</surname>
<given-names>Sarah G B</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff4">4</xref>
<author-comment content-type="other">
<p>
<sup>†</sup>Equally contributing first authors.</p>
</author-comment>
<xref ref-type="author-notes" rid="ddx289-FM1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ritter</surname>
<given-names>Dylan J</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
<xref ref-type="aff" rid="ddx289-aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Islam</surname>
<given-names>M Saharul</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buscher</surname>
<given-names>Nathalie</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zolkowska</surname>
<given-names>Dorota</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pride</surname>
<given-names>Michael C</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berg</surname>
<given-names>Elizabeth L</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>LaSalle</surname>
<given-names>Janine M</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ellegood</surname>
<given-names>Jacob</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lerch</surname>
<given-names>Jason P</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff2">2</xref>
<xref ref-type="aff" rid="ddx289-aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reiter</surname>
<given-names>Lawrence T</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silverman</surname>
<given-names>Jill L</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff1">1</xref>
<xref ref-type="corresp" rid="ddx289-cor1"></xref>
<author-comment content-type="other">
<p>
<sup>‡</sup>Equally contributing last authors.</p>
</author-comment>
<xref ref-type="author-notes" rid="ddx289-FM2"></xref>
<!--<email>jsilverman@ucdavis.edu</email>-->
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-9146-3339</contrib-id>
<name>
<surname>Dindot</surname>
<given-names>Scott V</given-names>
</name>
<xref ref-type="aff" rid="ddx289-aff4">4</xref>
<author-comment content-type="other">
<p>
<sup>‡</sup>Equally contributing last authors.</p>
</author-comment>
<xref ref-type="author-notes" rid="ddx289-FM2"></xref>
</contrib>
</contrib-group>
<aff id="ddx289-aff1">
<label>1</label>MIND Institute, School of Medicine, University of California, Davis, Sacramento, CA, USA</aff>
<aff id="ddx289-aff2">
<label>2</label>The Hospital for Sick Children, Mouse Imaging Centre, Toronto, ON, Canada</aff>
<aff id="ddx289-aff3">
<label>3</label>Departments of Neurology, Pediatrics and Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN, USA</aff>
<aff id="ddx289-aff4">
<label>4</label>Texas A&amp;M, College Station, TX, USA</aff>
<aff id="ddx289-aff5">
<label>5</label>Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada</aff>
<author-notes>
<fn id="ddx289-FM1">
<label>†</label>
<p>Equally contributing first authors.</p>
</fn>
<fn id="ddx289-FM2">
<label>‡</label>
<p>Equally contributing last authors.</p>
</fn>
<corresp id="ddx289-cor1"><label>*</label>To whom correspondence should be addressed at: MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Room 1001B, Research II Building 96, 4625 2nd Avenue, Sacramento, CA 95817, USA. Tel: 916 7348531; Fax: 916 7345089; Email: <email>jsilverman@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-07-19" pub-type="epub">
<day>19</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>10</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>26</volume>
<issue>20</issue>
<fpage>3995</fpage>
<lpage>4010</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="ddx289.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Maternally derived copy number gains of human chromosome 15q11.2-q13.3 (Dup15q syndrome or Dup15q) cause intellectual disability, epilepsy, developmental delay, hypotonia, speech impairments, and minor dysmorphic features. Dup15q syndrome is one of the most common and penetrant chromosomal abnormalities observed in individuals with autism spectrum disorder (ASD). Although ∼40 genes are located in the 15q11.2-q13.3 region, overexpression of the ubiquitin-protein E3A ligase (<italic>UBE3A</italic>) gene is thought to be the predominant molecular cause of the phenotypes observed in Dup15q syndrome. The <italic>UBE3A</italic> gene demonstrates maternal-specific expression in neurons and loss of maternal <italic>UBE3A</italic> causes Angelman syndrome, a neurodevelopmental disorder with some overlapping neurological features to Dup15q. To directly test the hypothesis that overexpression of <italic>UBE3A</italic> is an important underlying molecular cause of neurodevelopmental dysfunction, we developed and characterized a mouse overexpressing <italic>Ube3a</italic> isoform 2 in excitatory neurons. <italic>Ube3a</italic> isoform 2 is conserved between mouse and human and known to play key roles in neuronal function. Transgenic mice overexpressing <italic>Ube3a</italic> isoform 2 in excitatory forebrain neurons exhibited increased anxiety-like behaviors, learning impairments, and reduced seizure thresholds. However, these transgenic mice displayed normal social approach, social interactions, and repetitive motor stereotypies that are relevant to ASD. Reduced forebrain, hippocampus, striatum, amygdala, and cortical volume were also observed. Altogether, these findings show neuronal overexpression of <italic>Ube3a</italic> isoform 2 causes phenotypes translatable to neurodevelopmental disorders.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01NS097808</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="16"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>